Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin

Leukemia

Volumn 14, Issue 8, 2000, Pages 1444-1450

  Maksumova, L ^a   Ohnishi, K ^a   Muratkhodjaev, F ^a   Zhang, W ^a   Takeshita, A ^a   Ohno, R ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HMG CoA reductase; Lovastatin; Myeloid leukemia cells; P glycoprotein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GLYCOPROTEIN P; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; MEVALONIC ACID; MEVINOLIN; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0033908042     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401856     Document Type: Article

References (43)

1. Regulation of the mevalonate pathway
2. Evidence of post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins
3. Ras C-terminal processing enzymes - new drug targets?
4. Nucleoplasmic localization of prelamin A: Implications for prenylation-dependent lamin A assembly into the nuclear lamina
5. Evidence for modification of lamin B by a product of mevalonic acid
6. The discovery and development of HMG-CoA reductase inhibitors
7. HMG-CoA reductase inhibitors: Role in normal and malignant cells
8. Intracellular alkalization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease
9. Lovastatin induces growth inhibition and apoptosis in human malignant glioma
10. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP
11. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach
12. Effects of lovastatin on a human myeloma cell line: Increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein
13. Lovastatin effects on human breast carcinoma cells: Differential toxicity on an adriamycin-resistant derivative and influence on selenocysteine tRNAs
14. HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P-glycoprotein expressing cells
15. Human multidrug-resistant (MRP, p190) myeloid leukemia HL-60/ADR cells in vitro: Resistance to the mevalonate pathway inhibitor lovastatin
16. Characteristics of resistance to adryamicin in human myelogenous leukemia K-562 resistant to adryamicin and in isolated clones
17. FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in human promonocytic leukemia cell line
18. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
19. Mutant AF-2 domain of PML-RARa in retinoic acid-resistant NB4 cells: Differentiation induced by RA is triggered directly through PML-RARa and its down-regulation in acute promyelocytic leukemia
20. Coexpression of multidrug resistance gene (MDR-1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR-1-transduced human tumors transplanted in nude mice
21. Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
22. New flow cytometric method of minimally expressed multidrug-resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptovidin-RED 670 conjugate
23. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
25. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-X(L)
26. Expression of the multidrug resistance gene (MDR1) in non-small cell lung cancer
27. Role of P-glyco-protein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: Analysis of intracellular concentration of ATRA
28. Phase 1 study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
29. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin, and pravastatin on leukemic and normal bone marrow progenitors
30. Selective inhibition of primary acute myeloid leukemia cell growth by lovastatin
31. Mechanisms and genes of cellular suicide
32. Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptosis cell death
33. Inhibition of apoptosis by BCR-ABL is chronic myeloid leukemia
34. BCR-ABL maintains resistance of chronic myelogeneous leukemia cells to apoptotic cell death
35. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-X(L)
36. Bcl-x(L) is heterogeneously expressed by acute myeloblastic leukemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression
37. Overexpression of bcl-xl by cytotoxic drug exposure confers resistance to ionising radiation-induced internucleosomal DNA fragmentation
38. Inhibition of cell growth by lovastatin is independent of ras function
39. Cholesterol based antineoplastic strategies
40. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum
41. Role of multidrug resistance P-glycoproteins in cholesterol esterification
42. Cytoplasmic membrane cholesterol and doxorubicin cytoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells
43. Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts